[go: up one dir, main page]

AR004178A1 - Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma. - Google Patents

Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.

Info

Publication number
AR004178A1
AR004178A1 ARP960103748A AR10374896A AR004178A1 AR 004178 A1 AR004178 A1 AR 004178A1 AR P960103748 A ARP960103748 A AR P960103748A AR 10374896 A AR10374896 A AR 10374896A AR 004178 A1 AR004178 A1 AR 004178A1
Authority
AR
Argentina
Prior art keywords
procedure
formulation
pharmacy
pharmaceutical composition
same
Prior art date
Application number
ARP960103748A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR004178A1 publication Critical patent/AR004178A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un procedimiento para formulación de fármacos, que comprende mezclar partículas de un vehículo con una solución de un fármaco monohidrocloruro de[R-(Z)]-alfa-(metoximiimino)-alfa-(1-azabiciclo[2.2.2]-oct-3-il)acetonitrilo, en agua en unacan tidad de 1-3% en peso de solución a mezcla total,composiciones farmacéuticas utilizadas en él y el uso de dichas composiciones farmacéuticas en el tratamiento y/o profilaxis de la demencia.
ARP960103748A 1995-07-29 1996-07-25 Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma. AR004178A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process

Publications (1)

Publication Number Publication Date
AR004178A1 true AR004178A1 (es) 1998-11-04

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103748A AR004178A1 (es) 1995-07-29 1996-07-25 Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.

Country Status (25)

Country Link
EP (1) EP0841902A2 (es)
JP (1) JPH11510493A (es)
KR (1) KR19990035972A (es)
CN (1) CN1196677A (es)
AP (1) AP858A (es)
AR (1) AR004178A1 (es)
AU (1) AU716961B2 (es)
BG (1) BG102266A (es)
BR (1) BR9609804A (es)
CA (1) CA2228048A1 (es)
CZ (1) CZ24798A3 (es)
DZ (1) DZ2077A1 (es)
EA (2) EA199901055A1 (es)
HU (1) HUP9900521A3 (es)
IL (1) IL122897A0 (es)
MA (1) MA23953A1 (es)
MX (1) MX9800809A (es)
NO (1) NO980384L (es)
NZ (1) NZ315632A (es)
OA (1) OA10659A (es)
PL (1) PL325242A1 (es)
SK (1) SK11098A3 (es)
TR (1) TR199800156T1 (es)
UY (1) UY24297A1 (es)
WO (1) WO1997004750A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
IL138192A0 (en) * 1998-03-11 2001-11-25 Smithkline Beecham Plc Controlled release oral dosage forms
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
PT1591121E (pt) 2000-12-14 2009-07-20 Ortho Mcneil Janssen Pharm Processo para preparar produtos de hormona esteróide compreendendo um agente estabilizante na forma não cristalina
US20070202179A1 (en) * 2004-04-09 2007-08-30 FAULKNER Patrick Low Dose Pharmaceutical Products
WO2026018154A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with non-cns penetrant muscarinic antagonists
WO2026018155A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
EP0392803B1 (en) * 1989-04-13 2004-06-16 Beecham Group p.l.c. Novel compounds
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
AU6738496A (en) 1997-02-26
MA23953A1 (fr) 1997-04-01
CA2228048A1 (en) 1997-02-13
EA199901055A1 (ru) 2000-06-26
IL122897A0 (en) 1998-08-16
UY24297A1 (es) 1997-01-23
TR199800156T1 (xx) 1998-04-21
EA000740B1 (ru) 2000-02-28
EA199800179A1 (ru) 1998-10-29
WO1997004750A3 (en) 1997-03-27
CZ24798A3 (cs) 1998-06-17
BG102266A (en) 1998-10-30
MX9800809A (es) 1998-04-30
HUP9900521A3 (en) 2001-04-28
SK11098A3 (en) 1998-07-08
OA10659A (en) 2002-09-18
NZ315632A (en) 1999-11-29
CN1196677A (zh) 1998-10-21
NO980384D0 (no) 1998-01-28
AU716961B2 (en) 2000-03-09
WO1997004750A2 (en) 1997-02-13
AP9801170A0 (en) 1998-01-31
JPH11510493A (ja) 1999-09-14
KR19990035972A (ko) 1999-05-25
DZ2077A1 (fr) 2002-07-22
PL325242A1 (en) 1998-07-06
HUP9900521A2 (hu) 1999-06-28
EP0841902A2 (en) 1998-05-20
AP858A (en) 2000-07-12
BR9609804A (pt) 1999-07-06
NO980384L (no) 1998-03-26

Similar Documents

Publication Publication Date Title
PT101061A (pt) Composicoes farmaceuticas contendo anagolos da camptotecina e um composto de coordenacao de platina e seu uso na inibicao do crescimento de celulas tumorais
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
AR003455A1 (es) Derivados tetraciclicos, su uso en la preparacion de un medicamento, un metodo de tratamiento, una composicion farmaceutica y procesos para lapreparacion de una composicion farmaceutica y para preparar los compuestos.
HUT68251A (en) Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines and pharmaceutical compositions containing them
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
MX9300603A (es) Derivados tiaciclicos de piperidinilo.
IL91361A0 (en) Tricyclic compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
IL117824A (en) Pharmaceutical compositions containing 2-aryl-imidazol¬1,2-a¾pyridine-3-acetamide derivatives for treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia
ITMO920035A1 (it) Flacone contagocce particolarmente per prodotti farmaceutici attivabili all'uso per miscelazione
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
ES2076595T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
AR004178A1 (es) Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.
MX9401080A (es) Compuestos heteroaromaticos.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
FI944933A7 (fi) 7-disubstitoitu metyyli-4-okso-3H,5H-pyrrolo(3,2-d) pyrimidiini ja sit ä sisältäviä farmaseuttisia käyttöjä ja koostumuksia
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
PA8496701A1 (es) Polimorfos de un diclorhidrato cristalino de azobiciclo [2.2.2] oct- 3 - ilamina y sus composiciones farmaceuticas
IL67925A0 (en) Laevorotatory isomer of mequitazine,its preparation and pharmaceutical compositions containing it
IL105349A0 (en) Pharmaceutical compositions containing beta-carbolines,methods for the preparation thereof and compounds for use in the preparation thereof
FI822671L (fi) Aminoglykosidderivat, foerfaranden foer framstaellning av dem, farmaceutiska kompositioner innehaollande dem samt anvaendning av saodana derivat som laekemedel
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
MX9302578A (es) Agentes antivirales.
AR026756A1 (es) Nuevas combinaciones terapeuticas (s)-2-bencilamino-metil)-2,3,8,9-tetrahidro-7h-1,4-dioxino[2,3-e]indol-8-ona y neuroleticos para el tratamiento oprevencion de desordenes psicoticos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal